Matches in Wikidata for { <http://www.wikidata.org/entity/Q66047040> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q66047040 description "clinical trial" @default.
- Q66047040 description "ensayu clínicu" @default.
- Q66047040 description "klinisch onderzoek" @default.
- Q66047040 description "клінічне випробування" @default.
- Q66047040 name "Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer" @default.
- Q66047040 name "Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer" @default.
- Q66047040 type Item @default.
- Q66047040 label "Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer" @default.
- Q66047040 label "Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer" @default.
- Q66047040 prefLabel "Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer" @default.
- Q66047040 prefLabel "Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer" @default.
- Q66047040 P1132 Q66047040-A0323A35-E68D-4F61-9168-63D425FE9BFD @default.
- Q66047040 P131 Q66047040-A7FBCB77-92D7-49A7-AC7F-B9AC5D1F1274 @default.
- Q66047040 P1476 Q66047040-B46D906C-746E-45D2-AB20-7862F94E2DCE @default.
- Q66047040 P17 Q66047040-0B735C32-5229-42A0-8EA1-ADF5DBAB89E9 @default.
- Q66047040 P17 Q66047040-1FAD6DDA-F5B9-4A4D-979C-B3AD9C111F39 @default.
- Q66047040 P17 Q66047040-36370133-2182-4272-B415-AFB6101B200A @default.
- Q66047040 P17 Q66047040-3ACA1951-15AE-4AE5-B093-4D3041C15982 @default.
- Q66047040 P17 Q66047040-516644B6-3C63-49A5-BE9F-8CD432613477 @default.
- Q66047040 P17 Q66047040-519EDB2E-E830-4C0D-9B8A-6973F9059633 @default.
- Q66047040 P17 Q66047040-6524B8F4-9055-4773-9898-CE4102D82E29 @default.
- Q66047040 P17 Q66047040-EB88F9FD-D351-4C05-9E6D-719DC47D99A9 @default.
- Q66047040 P1813 Q66047040-785DF976-20F8-46D4-912D-28E46A4ADA56 @default.
- Q66047040 P3098 Q66047040-5F1974CF-F751-4A9B-8056-2F96E8868134 @default.
- Q66047040 P31 Q66047040-89551DB0-95C8-4806-947D-AF14C05B886B @default.
- Q66047040 P580 Q66047040-6A4B854C-8CCE-4506-8D7F-42C02285B1D8 @default.
- Q66047040 P582 Q66047040-52E086CA-A49A-461C-A8AF-C0A42EB2C639 @default.
- Q66047040 P6099 Q66047040-5B978884-B5FC-4436-89EA-00CECA335E2E @default.
- Q66047040 P6099 Q66047040-D6E53185-D07D-473A-B2E9-E072241CDDD9 @default.
- Q66047040 P6153 Q66047040-154EDE4E-527F-44D3-960C-04F8AF592AB1 @default.
- Q66047040 P6153 Q66047040-23358639-79BE-435B-89A0-92198A641F31 @default.
- Q66047040 P6153 Q66047040-356B7817-8432-440E-B416-A71220A7E8A2 @default.
- Q66047040 P6153 Q66047040-E6A402E4-21DD-48CE-BBC5-51B85837AE30 @default.
- Q66047040 P6153 Q66047040-ED2FB138-2033-4632-A5C7-AA1084AA22FF @default.
- Q66047040 P8363 Q66047040-6758EB32-737E-4899-9496-62CF7589361B @default.
- Q66047040 P1132 "+490" @default.
- Q66047040 P131 Q8646 @default.
- Q66047040 P1476 "A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Varlitinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as Second Line Systemic Therapy" @default.
- Q66047040 P17 Q17 @default.
- Q66047040 P17 Q28 @default.
- Q66047040 P17 Q29 @default.
- Q66047040 P17 Q30 @default.
- Q66047040 P17 Q334 @default.
- Q66047040 P17 Q36 @default.
- Q66047040 P17 Q408 @default.
- Q66047040 P17 Q865 @default.
- Q66047040 P1813 "TreeTopp" @default.
- Q66047040 P3098 "NCT03093870" @default.
- Q66047040 P31 Q30612 @default.
- Q66047040 P580 "2017-07-04T00:00:00Z" @default.
- Q66047040 P582 "2019-07-01T00:00:00Z" @default.
- Q66047040 P6099 Q42824440 @default.
- Q66047040 P6099 Q42824827 @default.
- Q66047040 P6153 Q192334 @default.
- Q66047040 P6153 Q29052 @default.
- Q66047040 P6153 Q30279912 @default.
- Q66047040 P6153 Q7896459 @default.
- Q66047040 P6153 Q7972509 @default.
- Q66047040 P8363 Q78089383 @default.